Stocksigma LogoStocksigma Logo

Onesource Specialty Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26

■ Revenue: 5,162 (+37.4% YoY | +15.0% QoQ) ■ EBITDA: 1,633 (+53.3% YoY | +32.4% QoQ) ■ EBITDA Margin (%): 31.6 (+329 bps YoY | +416 bps QoQ) ■ PAT: 575

Onesource Specialty Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26

Onesource Specialty Pharma Ltd · Outcome · 27 Oct 2026, 3:36 pm

Onesource Specialty Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) ■ Revenue: 5,162 (+37.4% YoY | +15.0% QoQ) ■ EBITDA: 1,633 (+53.3% YoY | +32.4% QoQ) ■ EBITDA Margin (%): 31.6 (+329 bps YoY | +416 bps QoQ) ■ PAT: 575 (+448.2% YoY | +130.0% QoQ) ■ EPS (INR): 5.01 (+450.5% YoY | +129.8% QoQ)

Original exchange filing (PDF)

More announcements from Onesource Specialty Pharma Ltd

All Onesource Specialty Pharma Ltd announcements